stockrowQIAGEN N.V.
QGEN Healthcare Diagnostics & Research
QIAGEN N.V.’s revenue for fiscal 2025 (year ended December 2025) was $2.1 billion, up 5.65% from fiscal 2024.
- Revenue
- +0.28%
- EPS
- +7.94%
- Free cash flow
- +30.5%
- Total debt
- +13.8%
Quarter to June 2026, against a year earlier
Follow QGEN
Alert me
QIAGEN N.V. (QGEN) Revenue growth
QIAGEN N.V.'s revenue growth over the twelve months to 30 June 2026 was 2.96%, down 2.7 percentage points from fiscal 2025 (5.65%). Over the past ten years it has ranged from −8.23% (fiscal 2023) to 22.5% (fiscal 2020); the current reading is higher than 64% of that period. That is below the Diagnostics & Research industry median of 8.99% and below the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 5.65% | 4.99 |
| FY2024 | 0.66% | 8.89 |
| FY2023 | −8.23% | (3.34) |
| FY2022 | −4.89% | (25.28) |
| FY2021 | 20.4% | (2.14) |
| FY2020 | 22.5% | 20.89 |
| FY2019 | 1.64% | (4.31) |
| FY2018 | 5.95% | 0.00 |
| FY2017 | 5.95% | 1.50 |
| FY2016 | 4.45% | 9.19 |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Jun 2026 | 0.28% | (1.55) |
| Mar 2026 | 1.83% | (1.86) |
| Dec 2025 | 3.69% | (2.43) |
| Sep 2025 | 6.12% | (1.37) |
| 42 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| BLLN BillionToOne, Inc. compare | 76.5% |
| GH Guardant Health, Inc. compare | 41.7% |
| MEDP Medpace Holdings, Inc. compare | 20.4% |
| RDNT RadNet, Inc. compare | 18.9% |
| GRAL GRAIL, Inc. compare | 17.5% |
| RVTY Revvity Inc. compare | 4.56% |
| QGEN QIAGEN N.V. | 2.96% |
| ICLR ICON PLC compare | 1.82% |
| CRL Charles River Laboratories International, Inc. compare | −1.16% |
| Diagnostics & Research industry median | 8.99% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on QGEN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement